We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBR:NYSENabors Industries Ltd. Analysis

Data as of 2026-04-19 - not real-time

$79.52

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nabors Industries (NBR) is trading at $79.52, which sits below its 20‑day SMA of $83.49 but above the 50‑day SMA of $78.73, indicating a short‑term pullback within a broader bullish framework (SMA‑200 at $53.87). The stock is hovering near a technical support level of $76.59 and faces resistance around $92.38, while the RSI of 47 suggests neutral momentum. A bearish MACD histogram (‑0.79) and decreasing volume add pressure to the near‑term outlook despite the overall bullish trend flag. Valuation appears attractive: a trailing P/E of 4.57 versus an industry average of 21.2 signals significant undervaluation, though the forward P/E of 73.96 reflects sharply lower projected earnings. The balance sheet is strained, with a debt‑to‑equity ratio of 176% and net debt exceeding cash by roughly $1.6 B, raising solvency concerns. Operating cash flow remains robust at $694 M, yet free cash flow has dwindled to $29 M, highlighting capital intensity. Volatility is high at 50.8% over the past 30 days and beta exceeds 1.4, pointing to amplified price swings. Recent market sentiment is optimistic, as evidenced by an “Extreme Greed” fear‑greed index reading of 90.21 and an 18.4% price gain since the last earnings release. Analyst activity is mixed: Barclays lifted its price target to $65, still below current levels, while a major shareholder trimmed its stake, suggesting cautious confidence. In sum, NBR offers a compelling valuation edge but is weighed down by leverage, weak forward earnings guidance, and heightened technical risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume
  • Proximity to technical support at $76.59
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap (P/E 4.57 vs industry 21.2)
  • Recent price momentum (+18.4% since earnings)
  • Support level providing downside cushion

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong ROE (28%) despite high leverage
  • Energy drilling demand fundamentals
  • Elevated debt load and weak forward earnings outlook

Key Metrics & Analysis

Financial Health

Revenue Growth9.30%
Profit Margin9.00%
P/E Ratio4.6
ROE28.32%
ROA3.54%
Debt/Equity176.32
P/B Ratio2.0
Op. Cash Flow$693.3M
Free Cash Flow$29.2M
Industry P/E21.2

Technical Analysis

TrendBullish
RSI47.1
Support$76.59
Resistance$92.38
MA 20$83.49
MA 50$78.73
MA 200$53.87
MACDBearish
VolumeDecreasing
Fear & Greed Index90.21

Valuation

Target Price$85.25
Upside/Downside7.21%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.47
Volatility50.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.